HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

860.685

-4.364-0.50%

Number of Gainers:3

Number of Losers:6

Number of Flat:4

PE:- -

High:881.520

Open:863.928

Low:841.556

Close:865.049

Volume:55.59M

Turnover:395.19M

Market Cap:144.12B

Float Cap:104.67B

Loading ...

HAOHAI BIOTEC Spends Approximately HK$740,800 to Repurchase 46,000 Shares on November 2

Angelalign Technology (SEHK:6699) Faces A Europe Patent Setback As Valuation Questions Grow

Simply Wall St.

Elite Founder Led Stocks To Own In October 2026

Simply Wall St.

FOSUN PHARMA Spends Approximately HK$5.2536 Million to Buy Back 320,000 Shares on October 30

Sisram Medical Acquires 34,800 Shares in Buyback Valued at Approximately HK$61,850

Sisram Medical Files HKEX Next Day Disclosure Return Announcing Share Buyback

Notice on Appointments and Dismissals of Zhang Shiying and Seventeen Other Comrades

Haohai Biotec Repurchases 16,900 Shares for HK$271,100 on October 29

Is 3SBio (SEHK:1530) Undervalued As ESMO Data Strengthens Its Lung Cancer Story?

Simply Wall St.

Sisram Medical Announces Extraordinary General Meeting

FOSUN PHARMA Spends HK$33.4126 Million to Repurchase 2 Million Shares on October 28

Shanghai Fosun Pharmaceutical Logs Higher Q3 Attributable Profit; Revenue Up

MT Newswires Live

HAOHAI BIOTEC Repurchases 62,500 Shares for Approximately HK$992,100 on October 27

Sinopharm Group Stock Advances 2.3% in Hong Kong

HAOHAI BIOTEC Spends HKD 558,900 to Repurchase 35,000 Shares on October 26

Sinopharm Group Stock Rises 3.8% in Hong Kong

Yunnan Recognizes and Cultivates 20 Provincial-Level Labor Brands, with Ruili Jade Carving Artisans Making the List

Shanghai Haohai Biological Technology (SEHK:6826) Q3 Results Deepen Margin Pressure

Simply Wall St.

How Patent Infringement Ruling Will Impact Angelalign Technology Stock

Simply Wall St.

Haohai Biotec Q1-Q3 2026 Net Profit Attributable to Shareholders Falls 46.53% YoY to About 163 Million Yuan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BK1593/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":860.68463,"timestamp":1793952530468,"preClose":865.0486,"halted":0,"volume":55592590,"delay":0,"changeRate":-0.005045,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-4.363953,"latestTime":"11-06 16:00:00","open":863.9281,"high":881.51965,"low":841.5564,"amount":395187575.5,"amplitude":0.046198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"pbRate":1.11105,"peRate":10.148077,"turnoverRate":0.002705,"increases":3,"decrements":7,"flats":3,"marketCap":144123646896,"floatMarketCap":104669312304},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":881.51965,"amplitude":0.046198,"preClose":865.0486,"low":841.5564,"pbRate":"1.11105","latestPrice":860.68463,"volume":55592590,"delay":0,"open":863.9281,"prevYearClose":1094.978,"prevWeekClose":798.351,"prevMonthClose":798.351,"prevQuarterClose":907.15,"fiveDayClose":798.351,"twentyDayClose":856.485,"sixtyDayClose":956.832,"secType":"PLATE","market":"HK","turnoverRate":0.002705,"peRate":10.148077,"marketCap":144123646896,"floatMarketCap":104669312304,"timestamp":1793952530468,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":3,"down":6,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1180628971","title":"HAOHAI BIOTEC Spends Approximately HK$740,800 to Repurchase 46,000 Shares on November 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1180628971","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180628971?lang=en_us&edition=fundamental","pubTime":"2026-11-02 18:00","pubTimestamp":1793613615,"startTime":"0","endTime":"0","summary":"On November 2, 2026, HAOHAI BIOTEC (06826) announced that the company spent approximately HK$740,800 to repurchase 46,000 shares.The repurchase price ranged from HK$15.9 to HK$16.12 per share.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679273053","title":"Angelalign Technology (SEHK:6699) Faces A Europe Patent Setback As Valuation Questions Grow","url":"https://stock-news.laohu8.com/highlight/detail?id=2679273053","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679273053?lang=en_us&edition=fundamental","pubTime":"2026-10-31 15:24","pubTimestamp":1793431471,"startTime":"0","endTime":"0","summary":"Angelalign Technology (SEHK:6699) is under fresh scrutiny after the Paris Local Division of the Unified Patent Court ruled that its Torque Ridges aligner systems infringe an Align Technology patent, triggering injunctions and product recalls across multiple EU countries.\nAngelalign Technology’s legal hit in Europe lands after a mixed run in the market, with the latest share price at HK$76.55 and a year-to-date share price return of 25.7%. The 1-year total shareholder return of 34.45%...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6021000-choice1-card/1788954194987","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6021000-choice1-card/1788954194987"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-faces-a-europe-patent-setback","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-faces-a-europe-patent-setback","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1593","DCF","GXDW","BK1583","06699","DECU","BK1100","RGLO","BK1587","FEBU","VGFPF","JOYT","VOTE","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679220165","title":"Elite Founder Led Stocks To Own In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2679220165","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679220165?lang=en_us&edition=fundamental","pubTime":"2026-10-31 11:40","pubTimestamp":1793418051,"startTime":"0","endTime":"0","summary":"The recent record crypto hack at Binance has reminded everyone how fragile trust can be when leaders are not visibly aligned with users. Founder led businesses often put their own reputation and wealth on the line, and this can create a powerful incentive to protect shareholder value. This article walks through three stocks run by their original builders, and explains why their commitment might matter to your portfolio now.\nThe three stocks highlighted here offer a compelling starting point...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/8043000-choice1-card/1789094663358","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/8043000-choice1-card/1789094663358"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/media/hkg-3888/kingsoft-shares/news/elite-founder-led-stocks-to-own-in-october-2026-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/media/hkg-3888/kingsoft-shares/news/elite-founder-led-stocks-to-own-in-october-2026-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIX","LU2488822045.USD","SG9999015945.SGD","SG9999015986.USD","IE00BVYPNP33.GBP","SG9999015978.USD","CHAT","ARTY","SG9999015952.SGD","IE00BMCWC346.EUR","VTHR","BK1593","QTOC","00867","IE00BGHQDM52.EUR","AIPO","SG9999004311.SGD","IE00BVYPNQ40.USD","IE00BYV24P56.USD","SG9999004220.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153121886","title":"FOSUN PHARMA Spends Approximately HK$5.2536 Million to Buy Back 320,000 Shares on October 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1153121886","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153121886?lang=en_us&edition=fundamental","pubTime":"2026-10-30 18:02","pubTimestamp":1793354535,"startTime":"0","endTime":"0","summary":"FOSUN PHARMA (02196) has announced that on October 30, 2026, the company spent approximately HK$5.2536 million to repurchase 320,000 shares at prices ranging from HK$16.09 to HK$16.5 per share.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK1593","02196","BK0188","BK0012","BK0187","BK0183","BK0060","BK0239","BK0028","BK0175","BK1515","BK0096","BK1191","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128024827","title":"Sisram Medical Acquires 34,800 Shares in Buyback Valued at Approximately HK$61,850","url":"https://stock-news.laohu8.com/highlight/detail?id=1128024827","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128024827?lang=en_us&edition=fundamental","pubTime":"2026-10-30 17:48","pubTimestamp":1793353694,"startTime":"0","endTime":"0","summary":"Sisram Medical Ltd (01696) has announced a share repurchase executed on October 30, 2026.The company bought back 34,800 of its own shares during the transaction.The buyback was carried out at prices...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","01696","BK1585","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679329920","title":"Sisram Medical Files HKEX Next Day Disclosure Return Announcing Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2679329920","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679329920?lang=en_us&edition=fundamental","pubTime":"2026-10-30 17:42","pubTimestamp":1793353341,"startTime":"0","endTime":"0","summary":"Sisram Medical Files HKEX Next Day Disclosure Return Announcing Share BuybackSisram Medical repurchased 34,800 shares for HKD 61,850 on October 30, 2026.Repurchase prices ranged from HKD 1.755 to HKD ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nNDL28RB6S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","01696","BK1100","00656","BK1585","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172397240","title":"Notice on Appointments and Dismissals of Zhang Shiying and Seventeen Other Comrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1172397240","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172397240?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:12","pubTimestamp":1793275940,"startTime":"0","endTime":"0","summary":"Notice on Appointments and Dismissals of Zhang Shiying and Seventeen Other Comrades, De Zheng Ren [2026] No. 9, issued to all county and city people's governments and all units directly under the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1209","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131517479","title":"Haohai Biotec Repurchases 16,900 Shares for HK$271,100 on October 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1131517479","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131517479?lang=en_us&edition=fundamental","pubTime":"2026-10-29 17:00","pubTimestamp":1793264413,"startTime":"0","endTime":"0","summary":"Haohai Biotec (06826) announced that on October 29, 2026, the company repurchased 16,900 shares for HK$271,100, at a repurchase price of HK$16 to HK$16.1 per share.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679210784","title":"Is 3SBio (SEHK:1530) Undervalued As ESMO Data Strengthens Its Lung Cancer Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2679210784","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679210784?lang=en_us&edition=fundamental","pubTime":"2026-10-29 11:35","pubTimestamp":1793244911,"startTime":"0","endTime":"0","summary":"3SBio (SEHK:1530) drew fresh attention after presenting long term Phase II data for its PD-1/VEGF bispecific antibody SSGJ-707 at the 2026 ESMO Congress, highlighting progression-free survival benefits in advanced non-small cell lung cancer.\nThe fresh ESMO data landed after a tough stretch for 3SBio, with the share price down 21.14% over 90 days and 44.30% year to date, even though the three year total shareholder return of 109.48% and five year total shareholder return of 116.33% point to...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/is-3sbio-sehk1530-undervalued-as-esmo-data-strengthens-its-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/is-3sbio-sehk1530-undervalued-as-esmo-data-strengthens-its-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1593","HK0000165453.HKD","BK1161","BK1583","01530","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678546840","title":"Sisram Medical Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2678546840","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678546840?lang=en_us&edition=fundamental","pubTime":"2026-10-28 18:18","pubTimestamp":1793182713,"startTime":"0","endTime":"0","summary":"Sisram Medical Announces Extraordinary General MeetingSisram Medical will hold an extraordinary general meeting on December 3, 2026, at Renaissance Harbour View Hotel Hong Kong.Shareholders will vote ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL84ZxvB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1100","BK1230","01696","00656","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186221543","title":"FOSUN PHARMA Spends HK$33.4126 Million to Repurchase 2 Million Shares on October 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1186221543","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186221543?lang=en_us&edition=fundamental","pubTime":"2026-10-28 17:16","pubTimestamp":1793178976,"startTime":"0","endTime":"0","summary":"On October 28, 2026, FOSUN PHARMA (02196) announced that it repurchased 2 million shares for HK$33.4126 million.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0175","BK0012","BK0183","BK0188","02196","BK1191","BK0196","600196","BK1515","BK0060","BK0187","BK1593","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678175509","title":"Shanghai Fosun Pharmaceutical Logs Higher Q3 Attributable Profit; Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175509","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678175509?lang=en_us&edition=fundamental","pubTime":"2026-10-27 18:49","pubTimestamp":1793098149,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical  posted 946 million yuan in profit attributable to shareholders of the listed company for the third quarter, up 15% from a year prior.EPS moved 16.13% higher year over year to 0.36 yuan, a Tuesday filing with the Hong Kong Exchange showed.For the three months ended Sept. 30, operating revenue was 10 billion yuan, an increase of 1.4% from the year-ago period, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02196","BK0239","BK0175","BK1593","BK0060","BK0012","BK0183","BK0188","BK0187","BK1191","BK1515","FCA","BK0028","BK0196","600196","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117386534","title":"HAOHAI BIOTEC Repurchases 62,500 Shares for Approximately HK$992,100 on October 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1117386534","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117386534?lang=en_us&edition=fundamental","pubTime":"2026-10-27 17:40","pubTimestamp":1793094014,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) announced that on October 27, 2026, it repurchased 62,500 shares of the company at a cost of approximately HK$992,100.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678121391","title":"Sinopharm Group Stock Advances 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2678121391","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678121391?lang=en_us&edition=fundamental","pubTime":"2026-10-27 16:32","pubTimestamp":1793089920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rose 2.3% to 16.30 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.7% to 23041.32.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 27% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.4%.Trading volume totaled 8.8 million shares, compared to the 50-day average of 5.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1191","BK4175","BK0188","BK0012","BK1197","BK0187","LU0640798160.USD","BK0028","BK0239","01099","BK0183","BK0060","SHTDY","BK1515","600196","BK0175","BK0196","02196","LU1115378108.SGD","BK1500","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152491077","title":"HAOHAI BIOTEC Spends HKD 558,900 to Repurchase 35,000 Shares on October 26","url":"https://stock-news.laohu8.com/highlight/detail?id=1152491077","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152491077?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:58","pubTimestamp":1793005092,"startTime":"0","endTime":"0","summary":"On October 26, 2026, HAOHAI BIOTEC (06826) announced that it spent HKD 558,900 to repurchase 35,000 shares.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678168212","title":"Sinopharm Group Stock Rises 3.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2678168212","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678168212?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:31","pubTimestamp":1793003460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 3.8% to 15.93 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 23211.81.The stock's rise snapped a two-day losing streak.Sinopharm Group Co. Ltd. closed 29% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 1.0%.Trading volume totaled 11.6 million shares, compared to the 50-day average of 5.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0012","BK0175","BK0239","LU0640798160.USD","BK1197","SHTDY","01099","BK0028","BK1593","BK0096","BK1500","BK0183","BK0060","BK1515","BK1191","BK4175","02196","600196","BK0187","BK0196","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142043830","title":"Yunnan Recognizes and Cultivates 20 Provincial-Level Labor Brands, with Ruili Jade Carving Artisans Making the List","url":"https://stock-news.laohu8.com/highlight/detail?id=1142043830","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142043830?lang=en_us&edition=fundamental","pubTime":"2026-10-25 18:20","pubTimestamp":1792923643,"startTime":"0","endTime":"0","summary":"Recently, the Yunnan Provincial Department of Human Resources and Social Security issued a notice recognizing and cultivating 20 provincial-level labor brands, among which Ruili Jade Carving Artisans...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1209","02135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678857331","title":"Shanghai Haohai Biological Technology (SEHK:6826) Q3 Results Deepen Margin Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2678857331","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678857331?lang=en_us&edition=fundamental","pubTime":"2026-10-25 04:29","pubTimestamp":1792873776,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology closed today at HK$15.67, with the stock treading water over the past week and quarter while investors waited for fresh numbers. Those numbers just arrived. For Q3 2026, the company reported total revenue of CN¥531.3m and basic earnings per share of CN¥0.22, leaving a trailing net profit margin of 4.9% against a sharply higher level a year earlier.\nThe immediate share price calm contrasts with a much tougher profit story. The real question now is how that...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/shanghai-haohai-biological-technology-sehk6826-q3-results-de","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/shanghai-haohai-biological-technology-sehk6826-q3-results-de","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677900910","title":"How Patent Infringement Ruling Will Impact Angelalign Technology Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2677900910","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677900910?lang=en_us&edition=fundamental","pubTime":"2026-10-24 18:31","pubTimestamp":1792837897,"startTime":"0","endTime":"0","summary":"In October 2026, Align Technology secured a ruling from the Paris Local Division of the UPC that Angelalign Technology’s Torque Ridges aligner systems infringe an Align patent. The ruling triggered a recall, product destruction orders, damages and sales restrictions across 17 EU member states, with the decision open to appeal.\nThe injunction and recall create direct pressure on Angelalign Technology’s European product portfolio, raising execution risk around manufacturing changes, legal...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6021000-choice1-card/1788954194987","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6021000-choice1-card/1788954194987"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/how-patent-infringement-ruling-will-impact-angelalign-techno","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/how-patent-infringement-ruling-will-impact-angelalign-techno","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1100","BK1593","BK1587","06699"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162318094","title":"Haohai Biotec Q1-Q3 2026 Net Profit Attributable to Shareholders Falls 46.53% YoY to About 163 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1162318094","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162318094?lang=en_us&edition=fundamental","pubTime":"2026-10-23 20:38","pubTimestamp":1792759099,"startTime":"0","endTime":"0","summary":"Haohai Biotec (06826) has released its results for the first three quarters of 2026, reporting operating revenue of approximately 1.71 billion yuan, a year-on-year decrease of 9.93%.Net profit...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}